AB
Anixa Biosciences Inc
🇺🇸XNAS.ANIXUnited StatesHealthcare
$2.66USDdown -0.03 (-1.12%)OpenDelayed4:16 PM
Price$2.66-0.03 (-1.12%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US03528H1095
- CUSIP
- 45069V104
Company
- Employees
- 4
- Headquarters
- San Jose, United States
- Website
- https://www.anixa.com
- CEO
- Dr. Amit Kumar Ph.D.
Market
- Shares outstanding
- 34.8M
- Market cap
- $92.47M
Highlights
- Market cap
- $94.91M
- EPS LTM
- -$0.31
- P/E LTM
- -11.06
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$10.42M+6.23%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$7.38M-7.76%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.